82925-02-8

Basic information

• Product Name: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE
• Synonyms: 4-[2-(6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-2-ISOQUINOLINYL)ETHYL]ANILINE;4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE;[4-[2-(6,7-DiMethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]aMine;BenzenaMine, 4-[2-(3,4-dihydro-6,7-diMethoxy-2(1H)-isoquinolinyl)ethyl]-;4-(2-(6,7-DiMethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)aniline;EOS-62095
• CAS NO: 82925-02-8
• Molecular Formula: C₁₉H₂₄N₂O₂
• Molecular Weight: 312.41
• Product Categories: Amines;Aromatics;Heterocycles
• Mol File: 82925-02-8.mol
• Article Data: 28

Chemical Properties

• Melting Point: 129 °C
• Boiling Point: 473.704 °C at 760 mmHg
• Flash Point: 240.288 °C
• Appearance: /
• Density: 1.132 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.592
• Storage Temp.: -20°C Freezer, Under inert atmosphere
• Solubility: Soluble in dichloromethane, ethyl acetate and methanol.
• PKA: 8.00±0.20(Predicted)
• CAS DataBase Reference: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE(82925-02-8)
• EPA Substance Registry System: 4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE(82925-02-8)

Safety Data

• Hazardous Substances Data: 82925-02-8(Hazardous Substances Data)

Usage

Description

4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE is a white solid compound that serves as an intermediate in the preparation of Elacridar, a drug used to treat various conditions.

Uses

Used in Pharmaceutical Industry:
4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]-BENZENAMINE is used as an intermediate for the preparation of Elacridar, a drug that has potential applications in treating various conditions. Its role as an intermediate is crucial in the synthesis process, enabling the development of effective pharmaceuticals.

InChI:InChI=1/C19H24N2O2/c1-22-18-11-15-8-10-21(13-16(15)12-19(18)23-2)9-7-14-3-5-17(20)6-4-14/h3-6,11-12H,7-10,13,20H2,1-2H3

Upstream product

• 1745-07-9 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 2328-12-3 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline monohydrochloride 
• 50434-36-1 4-nitrophenylacetyl chloride 
• 82924-82-1 1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-(4-nitro-phenyl)-ethanone 
• 104-03-0 4-nitrobenzeneacetic acid 
• 5339-26-4 (4-nitrophenyl)ethyl bromide 
• 100-27-6 2-(4-nitrophenyl)ethanol 
• 82925-01-7 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-(4-nitrophenyl)ethyl]-isoquinoline 
• 1018524-30-5 2-(4-Amino-phenyl)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethanone 

Downstream Products

• 1187575-81-0 C₄₀H₃₇N₃O₅ 
• 849675-46-3 2-(2-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-ethyl)phenyl)-2H-tetrazol-5-yl)-4,5-dimethoxyaniline 
• 849675-66-7 encequidar 
• 206873-63-4 tariquidar 
• 849668-91-3 2-amino-N-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-4,5-dimethoxybenzamide 

Relevant articles and documents

ACETAMIDO-PHENYLBENZAMIDE DERIVATIVES AND METHODS OF USING THE SAME

The present disclosure relates to compounds of Formula (I): and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of disorders in which expression of P-glycoprotein and/or cytochrome P450 (e.g., CYP3A4) is modulated (e.g., cancers which have developed multi-drug resistance).

4-hydroxyquinoline derivative as well as preparation method and application thereof in antitumor drugs

The invention belongs to the technical field of medicines, and particularly relates to a 4-hydroxyquinoline derivative as well as a preparation method and application thereof, the 4-hydroxyquinoline derivative can be used as a P-gp inhibitor to reverse dr

Dimethoxy tetrahydroisoquinoline substituted purine derivative as well as preparation method and application thereof in anti-tumor drugs

The invention belongs to the technical field of medicines, and particularly relates to a dimethoxy tetrahydroisoquinoline substituted purine derivative and a preparation method thereof. The dimethoxy tetrahydroisoquinoline substituted purine derivative ca